ProShare Advisors’s Tandem Diabetes Care TNDM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $278K | Sell |
14,919
-545
| -4% | -$10.2K | ﹤0.01% | 1499 |
|
|
2025
Q1 | $296K | Sell |
15,464
-4,325
| -22% | -$82.9K | ﹤0.01% | 1422 |
|
|
2024
Q4 | $713K | Buy |
19,789
+5,903
| +43% | +$213K | ﹤0.01% | 1071 |
|
|
2024
Q3 | $589K | Buy |
+13,886
| New | +$589K | ﹤0.01% | 1045 |
|
|
2023
Q1 | – | Sell |
-4,934
| Closed | -$222K | – | 1905 |
|
|
2022
Q4 | $222K | Buy |
4,934
+402
| +9% | +$18.1K | ﹤0.01% | 1426 |
|
|
2022
Q3 | $217K | Sell |
4,532
-28
| -0.6% | -$1.34K | ﹤0.01% | 1354 |
|
|
2022
Q2 | $270K | Sell |
4,560
-1,765
| -28% | -$105K | ﹤0.01% | 1269 |
|
|
2022
Q1 | $735K | Sell |
6,325
-1,007
| -14% | -$117K | ﹤0.01% | 1059 |
|
|
2021
Q4 | $1.1M | Buy |
7,332
+1,485
| +25% | +$223K | ﹤0.01% | 970 |
|
|
2021
Q3 | $698K | Buy |
5,847
+3,582
| +158% | +$428K | ﹤0.01% | 1033 |
|
|
2021
Q2 | $221K | Buy |
+2,265
| New | +$221K | ﹤0.01% | 2095 |
|
|
2020
Q2 | – | Sell |
-3,265
| Closed | -$210K | – | 1679 |
|
|
2020
Q1 | $210K | Sell |
3,265
-4,336
| -57% | -$279K | ﹤0.01% | 996 |
|
|
2019
Q4 | $453K | Buy |
7,601
+1,214
| +19% | +$72.4K | ﹤0.01% | 1118 |
|
|
2019
Q3 | $377K | Buy |
6,387
+992
| +18% | +$58.6K | ﹤0.01% | 1102 |
|
|
2019
Q2 | $348K | Sell |
5,395
-150
| -3% | -$9.68K | ﹤0.01% | 1163 |
|
|
2019
Q1 | $352K | Buy |
5,545
+167
| +3% | +$10.6K | ﹤0.01% | 1182 |
|
|
2018
Q4 | $204K | Sell |
5,378
-860
| -14% | -$32.6K | ﹤0.01% | 1365 |
|
|
2018
Q3 | $267K | Buy |
+6,238
| New | +$267K | ﹤0.01% | 1435 |
|
|
2014
Q2 | – | Sell |
-932
| Closed | -$206K | – | 2609 |
|
|
2014
Q1 | $206K | Buy |
+932
| New | +$206K | ﹤0.01% | 2501 |
|